EUVIMEDEUVIMED entdecken
Systematische Übersicht

Unlocking diagnosis of sarcopenia: The role of circulating biomarkers – A clinical systematic review

F Veronesi, F Salamanna, V Borsari, A Ruffilli, C Faldini, G Giavaresi

Mechanisms of Ageing and Development · 2024-12 · 222 · 112005

DOI: 10.1016/j.mad.2024.112005 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Mechanisms of Ageing and Development, 2024-12. Verfasst von F Veronesi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, Bologna 40136, Italy. Hauptthemen laut MEDLINE: Sarcopenia, Biomarkers. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 89 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcopenia, the gradual loss of muscle mass, strength, and function with age, poses a significant risk to older adults, making early diagnosis crucial for preventing disability and enhancing quality of life. Biomarkers are vital for the early detection, monitoring progression, and assessing the efficacy of treatments for sarcopenia, offering a detailed evaluation of muscle health. This systematic review examined the clinical potential of circulating biomarkers in sarcopenia by analyzing studies up to May 2024 from PubMed, Scopus, Web of Science. A total of 45 studies involving 641,730 patients were reviewed, revealing notable biomarker differences between sarcopenic and non-sarcopenic individuals. Sarcopenic patients exhibited lower levels of certain microRNAs, hemoglobin, albumin, and anti-inflammatory factors, alongside higher levels of red and white blood cells, pro-inflammatory factors, growth factors, matrix proteins, free thyroxine, cortisol, and adiponectin. Additionally, they had lower levels of irisin, free triiodothyronine, and insulin, with reduced phosphatidylcholines and elevated spermidine. The studies were generally of fair to good quality, but due to heterogeneity, a meta-analysis was not feasible. The review underscores the need for standardized biomarkers and diagnostic criteria and suggests that improving outcomes for sarcopenic patients may involve addressing inflammation, metabolic, and hormonal issues through nutrition, medication, and exercise.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaBiomarkersHumansAgedMaleFemale

Stichwörter der Autor:innen

Circulating biomarkersEarly diagnosisSarcopeniaSystematic review

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, Bologna 40136, Italy.
  • Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, Bologna 40136, Italy. Electronic address: francesca.salamanna@ior.it.
  • 1st Orthopaedic and Traumatologic Clinic, IRCCS Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, Bologna 40136, Italy; Department of Biomedical and Neuromotor Science - DIBINEM, University of Bologna, Bologna, Italy.

Zitieren

APA

Veronesi, F., Salamanna, F., Borsari, V., Ruffilli, A., Faldini, C., & Giavaresi, G. (2024). Unlocking diagnosis of sarcopenia: The role of circulating biomarkers – A clinical systematic review. Mechanisms of Ageing and Development, 222, 112005. https://doi.org/10.1016/j.mad.2024.112005

Vancouver

Veronesi F, Salamanna F, Borsari V, Ruffilli A, Faldini C, Giavaresi G. Unlocking diagnosis of sarcopenia: The role of circulating biomarkers – A clinical systematic review. Mechanisms of Ageing and Development. 2024;222:112005. doi:10.1016/j.mad.2024.112005

BibTeX
@article{Veronesi2024,
  author = {Veronesi, F and Salamanna, F and Borsari, V and Ruffilli, A and Faldini, C and Giavaresi, G},
  title = {Unlocking diagnosis of sarcopenia: The role of circulating biomarkers – A clinical systematic review},
  journal = {Mechanisms of Ageing and Development},
  year = {2024},
  volume = {222},
  pages = {112005},
  doi = {10.1016/j.mad.2024.112005}
}
Kostenlos starten →